Patients Coming Off Weight-Loss Injections Gain Back Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis indicates that individuals who stop using new GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who end traditional diet and exercise plans.

Findings released in a leading medical journal shows that while obese people frequently drop about a fifth of their total mass while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.

"People buying these drugs should be aware of the potential of rapid rebound weight gain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

This pace of recovery means a reversion to pre-treatment mass within about a year and a half.

Weighing Therapies

The research, which examined dozens of trials involving over 9,000 of patients, compared the outcomes of the injectable medications with conventional dieting.

The team note that people who shed pounds through lifestyle changes alone usually have a more gradual creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Rebound

Experts propose the way of the injections explains the heightened regain.

These medications mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Artificially providing the hormone levels several times higher than normal might result in the system to produce less of its own natural hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this hormone supplement leads to appetite is unsuppressed, making overeating a significant risk."

An Ongoing Disease?

Health authorities recommend the injections for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, due to the likelihood of weight regain, the therapy might need to be life-long.

This view is echoed by drug manufacturers, who state that the results "emphasize the chronic character of excess weight," similar to managing diseases like high blood pressure.

Patient Accounts

Users who have discontinued the medication explain a powerful resurgence of hunger.

"It was like a switch that goes on and I was suddenly extremely hungry," recalled one woman.

The struggle is worsened if individuals have not developed lasting dietary or behavioural changes during therapy.

Significant Use

Figures indicate that millions of people in the UK have used these injections in the last 12 months, with desire continuing to grow.

• Adoption is greater among females compared to males.
• The 40s and 50s age group shows the highest usage rates.
• Many access the drugs through private prescriptions rather than public health services.

Finally, clinicians emphasize that while these medications are effective tools for weight loss, they are not a standalone fix and maintained weight loss likely depends on combined behavioural changes.